Announcement of Establishment of a Subsidiary in Bangladesh

Remedy & Company Corporation is opening a wholly owned subsidiary in Dhaka, capital of People's Republic of Bangladesh.

The objective of this opening is to strengthen our business in field of DX/DTx. We will launch a department specialized in data science and data management in Dhaka, which has abundant IT related human resources to promote our services to the country and expand its presence in Southeastern Asia region.

REMEDY & COMPANY (BD) LTD.

About Remedy & Company:
Remedy & Company Corporation (formerly known as intellim Holdings Corporation) was established in 2018.
Its predecessor, intellim Corporation, which was founded in 2005 with main aim of developing CRO business.
Subsequently, intellim Holdings Corporation (now known as Remedy & Company Corporation) was established in 2018 as the core driving intellim Corporation and other group companies in Japan and abroad to create innovative solutions in drug development within Japan and abroad.
In April 2022, the company changed its name to Remedy & Company Corporation and made a new start with the goal of becoming a global health tech platform that transcends the boundaries of a CRO. Remedy & Company Corporation oversees group companies including intellim Corporation, iRIS Corporation, Quantum Healthcare Corporation and Remedy XR Corporation, and its business objective is to achieve further growth for the world, healthcare, and customers, while utilizing the latest technology and innovation.
Head office moved to the TOKYO TORCH Tokiwabashi Tower in January 2023.
Remedy group currently has offices in 8 countries. (as of February 2023)